Publications
Optimizing quantification of MK6240 tau PET in unimpaired older adults
U.S. POINTER Study Group 2023, , NeuroImage, vol. 265, 119761. https://doi.org/10.1016/j.neuroimage.2022.119761
Neuroinflammation co-localizes highly with tau in amnestic mild cognitive impairment
Appleton, J, Funk, Q, Bradbury, K, Yu, M, Faridar, A, Beers, D, Appel, SH, Fujita, M, Masdeu, JC & Pascual, B 2022, , Alzheimers and Dementia, vol. 18, no. S1, e068025. https://doi.org/10.1002/alz.068025
Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease
Faridar, A, Vasquez, M, Thome, AD, Yin, Z, Xuan, H, Wang, JH, Wen, S, Li, X, Thonhoff, JR, Zhao, W, Zhao, H, Beers, DR, Wong, STC, Masdeu, JC & Appel, SH 2022, , Acta Neuropathologica Communications, vol. 10, no. 1, 144. https://doi.org/10.1186/s40478-022-01447-z
Imaging Neuroinflammation in Neurodegenerative Disorders
Masdeu, JC, Pascual, B & Fujita, M 2022, , Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 63, no. Suppl 1, pp. 45S-52S. https://doi.org/10.2967/jnumed.121.263200
Imaging Neuroinflammation in Neurodegenerative Disorders
Masdeu, JC, Pascual, B & Fujita, M 2022, , Journal of Nuclear Medicine, vol. 63, no. Suppl 1, pp. 45S-52S. https://doi.org/10.2967/JNUMED.121.263200
ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion
the ALLFTD consortium 2022, , Nature Methods, vol. 19, no. 6, pp. 683-686. https://doi.org/10.1038/s41592-022-01458-7
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders
Gendron, TF, Heckman, MG, White, LJ, Veire, AM, Pedraza, O, Burch, AR, Bozoki, AC, Dickerson, BC, Domoto-Reilly, K, Foroud, T, Forsberg, LK, Galasko, DR, Ghoshal, N, Graff-Radford, NR, Grossman, M, Heuer, HW, Huey, ED, Hsiung, GYR, Irwin, DJ, Kaufer, DI, Leger, GC, Litvan, I, Masdeu, JC, Mendez, MF, Onyike, CU, Pascual, B, Ritter, A, Roberson, ED, Rojas, JC, Tartaglia, MC, Wszolek, ZK, Rosen, H, Boeve, BF, Boxer, AL & ALLFTD consortium 2022, , Cell Reports Medicine, vol. 3, no. 4, 100607. https://doi.org/10.1016/j.xcrm.2022.100607
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders
ALLFTD consortium 2022, , Cell Reports Medicine, vol. 3, no. 4, pp. 100607. https://doi.org/10.1016/j.xcrm.2022.100607
Translocator Protein 18 kDa PET Imaging Highlights Asymptomatic Isolated Cerebellar Dysplasia
Pascual, B, Hodics, T, Funk, Q, Cykowski, MD, Nakawah, MO & Masdeu, JC 2022, , Neurology, vol. 98, no. 13, pp. 538-539. https://doi.org/10.1212/WNL.0000000000200221
Proposed research criteria for prodromal behavioural variant frontotemporal dementia
ALLFTD consortium 2022, , Brain, vol. 145, no. 3, pp. 1079-1097. https://doi.org/10.1093/brain/awab365
The PET tracer [11C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer's disease
Li, W, Wang, Y, Lohith, TG, Zeng, Z, Tong, L, Mazzola, R, Riffel, K, Miller, P, Purcell, M, Holahan, M, Haley, H, Gantert, L, Hesk, D, Ren, S, Morrow, J, Uslaner, J, Struyk, A, Wai, JMC, Rudd, MT, Tellers, DM, McAvoy, T, Bormans, G, Koole, M, Van Laere, K, Serdons, K, De Hoon, J, Declercq, R, De Lepeleire, I, Pascual, MB, Zanotti Fregonara, P, Yu, M, Arbones, V, Masdeu, JC, Cheng, A, Hussain, A, Bueters, T, Anderson, MS, Hostetler, ED & Basile, AS 2022, , Science translational medicine, vol. 14, no. 627, eabg3684, pp. eabg3684. https://doi.org/10.1126/scitranslmed.abg3684
The PET tracer [11C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer's disease
Li, W, Wang, Y, Lohith, TG, Zeng, Z, Tong, L, Mazzola, R, Riffel, K, Miller, P, Purcell, M, Holahan, M, Haley, H, Gantert, L, Hesk, D, Ren, S, Morrow, J, Uslaner, J, Struyk, A, Wai, JMC, Rudd, MT, Tellers, DM, McAvoy, T, Bormans, G, Koole, M, Van Laere, K, Serdons, K, De Hoon, J, Declercq, R, De Lepeleire, I, Pascual, MB, Zanotti Fregonara, P, Yu, M, Arbones, V, Masdeu, JC, Cheng, A, Hussain, A, Bueters, T, Anderson, MS, Hostetler, ED & Basile, AS 2022, , Science translational medicine, vol. 14, no. 627, eabg3684. https://doi.org/10.1126/scitranslmed.abg3684
The PET tracer [11C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer's disease
Li, W, Wang, Y, Lohith, TG, Zeng, Z, Tong, L, Mazzola, R, Riffel, K, Miller, P, Purcell, M, Holahan, M, Haley, H, Gantert, L, Hesk, D, Ren, S, Morrow, J, Uslaner, J, Struyk, A, Wai, JMC, Rudd, MT, Tellers, DM, McAvoy, T, Bormans, G, Koole, M, Van Laere, K, Serdons, K, De Hoon, J, Declercq, R, De Lepeleire, I, Pascual, MB, Zanotti-Fregonara, P, Yu, M, Arbones, V, Masdeu, JC, Cheng, A, Hussain, A, Bueters, T, Anderson, MS, Hostetler, ED & Basile, AS 2022, , Science translational medicine, vol. 14, no. 627, eabg3684, pp. eabg3684. https://doi.org/10.1126/scitranslmed.abg3684
Alterations in brain synaptic proteins and mRNAs in mood disorders: a systematic review and meta-analysis of postmortem brain studies
Leung, E, Lau, EW, Liang, A, de Dios, C, Suchting, R, Östlundh, L, Masdeu, JC, Fujita, M, Sanches, M, Soares, JC & Selvaraj, S 2022, , Molecular Psychiatry, vol. 27, no. 3, pp. 1362-1372. https://doi.org/10.1038/s41380-021-01410-9
Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies
Cykowski, MD, Arumanayagam, AS, Powell, SZ, Rivera, AL, Abner, EL, Roman, GC, Masdeu, JC & Nelson, PT 2022, , Acta Neuropathologica, vol. 143, no. 5, pp. 531-545. https://doi.org/10.1007/s00401-022-02416-5
In Alzheimer-prone brain regions, metabolism and risk-gene expression are strongly correlated
Ye, F, Funk, Q, Rockers, E, Shulman, JM, Masdeu, JC, Pascual, B & Alzheimers Disease Neuroimaging Initiative 2022, , Brain communications, vol. 4, no. 5, pp. fcac216. https://doi.org/10.1093/braincomms/fcac216
In Alzheimer-prone brain regions, metabolism and risk-gene expression are strongly correlated
Ye, F, Funk, Q, Rockers, E, Shulman, JM, Masdeu, JC & Pascual, B 2022, , Brain Communications, vol. 4, no. 5, fcac216. https://doi.org/10.1093/braincomms/fcac216
Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease
Alzheimers Disease Neuroimaging Initiative 2021, , Nature Communications, vol. 12, no. 1, 4001. https://doi.org/10.1038/s41467-021-24220-7
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
Alzheimers Disease Neuroimaging Initiative 2021, , Translational Psychiatry, vol. 11, no. 1, 585. https://doi.org/10.1038/s41398-021-01709-9
Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
for the Alzheimer’s Disease Neuroimaging Initiative 2021, , Translational Psychiatry, vol. 11, no. 1, 483. https://doi.org/10.1038/s41398-021-01602-5